harry .. why do you feel the need to continuously display your stupidity ..
I do not short , ever , but if i did , it certainly would not be for a large cap , utility type stock , that might
move 1/2% ?? I'd be shorting something that could move 10% or more and it would surely not be a
dividend stock , there's plenty out there ..
Just like day trading ... a day trader needs real price movement to make any money ... garce
There is at present -- so far as mgmt has deigned to inform us -- no clear path forward for submission of an NDA for Dexasite. The last CC disclosed that Europe will require an additional "small" clinical trial before an NDA can be submitted there. As far as the shareholders know, the FDA remains non-committal, even 4 1 /2 months after the mid-December meeting. If the FDA follows the European lead, as it did when it reversed itself and decided that existing clinical data might support an NDA after all, it will require an additional clinical trial. I find it telling that apparently no deep-pocketed pharma company will step forward with the necessary funding.
Agree, I am in a little over $6 & can handle a 10-20% down turn. When you look at the potential the risk reward is worth taking. GLTA longs.
Read where they will be cutting expenditures by 30%.. Where does that put Orig? If they lease rigs for 30% less? I know that don't make a lot of sense? But????
"2015 began with a significant accomplishment for RINTEGA(R)—the granting of Breakthrough Therapy Designation for the treatment of adult patients with EGFRvIII-positive glioblastoma. We believe this designation underscores RINTEGA's therapeutic potential for these patients," said Anthony Marucci, Co-founder, President and Chief Executive Officer. "To this end, we look forward to presenting updated data from the ReACT study in the recurrent setting at ASCO and eagerly await data from the fully enrolled ACT IV study in the frontline setting.
Shame how crooked Wall Street is. 12 trading days ago this was $12. Shaved off 3/4's of a Billion market cap on nothing but good news in less than 3 weeks.
has been corrupted by money from foreign governments?
Faggy, the Contard Supreme Court ruled that money is speech and that giant donations do NOT corrupt.
Why do you want to deny people their free speech rights like the Supreme Court encourages?
Adjusted EBITDA positive during seven years
Adjusted EBITDA (in 1,000)
Why should the separation between GOOG and GOOGL be greater than the current $8-10 range? The ($8-10) premium for voting rights means more to the institutional owners than it does to the retail investors.
Director, Technical Services Zogenix, Inc.
Department: Technical Services
Location: Emeryville, CA
Zogenix' Technical Operations and Product Supply team is committed to delivering tangible benefits to patients and stakeholders by combining medical product innovation and operations excellence in developing, supporting, manufacturing and delivering products. TechOps is responsible for integrating all operations functions such as engineering, manufacturing, analysis, supply chain, procurement, operational excellence, capacity management, distribution and logistics for all Zogenix clinical and commercial products.
The Director of Technical Services is responsible for establishing and executing the overall technical strategy for the TechOps group in support of Zogenix' business plan. The position leads, plans, organizes and directs Process and Equipment Engineering activities as well as Qualification, Validation, Analysis and Documentation in support of industrialization and production of Zogenix clinical and commercial products.
This position is responsible for managing, supporting, and providing direction and leadership to team and functional leaders as well as deploying internal and contracted resources in the execution of all Technical Services duties. The incumbent will establish and maintain positive and productive relationships with domestic and international third-party technical partners and contractors as well as ensuring that technical capabilities, manufacturing capacity and product documentation meet or exceed all customer and industry requirements for quality, performance, compliance and cost.
The incumbent has budgetary responsibility for all group expenses as well as major projects, capital expenditures and support systems both internally and at supply chain partners.
George has got to own the record for the most losses by a publicly traded company. He has lost billions and billions of dollars and he is very proud of that. He is Greek after all. In Greece they try to see who can lose the most money. The dumbest CEO's in the world.
The last sentence about short sellars/purgatory I assume was yours, unless Prue took a little license there...
No actually I didnt.....thats why I am on here complaining when it acts so poorly. I bought at $27 44 and have yet to sell. I should have sold many times but didnt. I think it acts like a turd. I expected $34 long ago. . $32 is now my target